The U.K. drug marketing body, the Prescription Medicines Code of Practice Authority (PMCPA), is once again taking action against Novartis' U.K. business, which has become a repeat offender in terms of ...

ZoomRx has dug into its data to see what messages resonate with healthcare professionals (HCPs) at different stages in pharma launches, generating a roadmap of which themes drugmakers should push and ...

It's rare to make it through an episode of your favorite show without seeing a commercial for a prescription drug that includes a lengthy list of side effects and a prompt to speak with a doctor. And ...

New data analysis by University of Bath and Lund University academics reveals that public health in the UK could be undermined by a failing system of drug company self-regulation. The research shows ...

WASHINGTON (Reuters) - Quicker drug approvals and sophisticated marketing campaigns may be putting more patients at risk of dangerous side-effects but the same techniques might be put to use to ...

In a new draft guidance, the US Food and Drug Administration (FDA) has provided details on the clinical investigation requirements that sponsors of new drugs must meet to obtain three years of ...